Featured Research

from universities, journals, and other organizations

Treatment of retinal disease more frequently involves eye injections

Date:
March 8, 2010
Source:
JAMA and Archives Journals
Summary:
Use of medications injected directly into the eye appears to be an increasingly common treatment for age-related macular degeneration in one region of Canada, but only a small proportion of ophthalmologists perform the procedure, according to a new study.

Use of medications injected directly into the eye appears to be an increasingly common treatment for age-related macular degeneration in one region of Canada, but only a small proportion of ophthalmologists perform the procedure, according to a report in the March issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Age-related macular degeneration is the leading cause of blindness in Western nations, according to background information in the article. The development of vascular endothelial growth factor inhibitors -- medications that prevent the formation of new blood vessels -- has revolutionized the treatment of this condition. One such drug, bevacizumab, was approved for treating colorectal cancer in Canada in 2005 but has been used off-label since to treat retinal disease. A second, ranibizumab, was approved in 2007.

"Access to new vascular endothelial growth factor inhibitor therapies may be limited by a number of factors, including regulatory approval, cost and the necessity of administering these drugs via serial intravitreal injections under the care of an ophthalmologist," the authors write. Widespread uptake of these therapies would significantly affect the practice of many ophthalmologists, note Robert J. Campbell, M.D., M.Sc., of Queens University and Hotel Dieu Hospital, Ontario, Canada, and colleagues. To evaluate patterns of care for age-related macular degeneration, they analyzed monthly fee claims for intravitreal injections submitted to the Ontario Health Insurance Plan between 2000 and 2008 and linked procedures to the clinicians who performed them.

"Following the regulatory approval of bevacizumab in September 2005, the rate of intravitreal injections in Ontario rapidly grew eight-fold to its peak level in November 2007 (growth from 3.5 to 25.9 injections per 100,000 Ontarians per month)," the authors write. "This striking upswing in injections preceded the availability of ranibizumab in Ontario by almost a year."

However, the number of ophthalmologists administering these injections increased at a slower rate, from 39 (10 percent of all ophthalmologists) in September 2005 to 64 (15 percent of all ophthalmologists) in November 2007. Among those performing the injections, the median (midpoint) monthly number of procedures increased from seven in 2005 to 30.5 in the first quarter of 2008. "In 2007, more than 50 percent of intravitreal injections were performed by just 3 percent of Ontario's ophthalmologists, and the monthly number of injections performed by this group of intensive service providers grew from 162 to 1,436 between September 2005 and November 2007," the authors write.

The findings highlight the concentration of the procedures among a small number of providers and raise concerns about access to the treatment in the future, they note. "New procedures often diffuse over time from a small group of early adopters to a broader section of physicians. However, the specialized skills required to diagnose and manage age-related macular degeneration, combined with limited access to necessary diagnostic testing equipment, may restrict such diffusion in this case."

"The remarkable number of injection procedures required with current administration regimens, together with the limited supply of ophthalmologists and retina subspecialists, has the potential to limit equitable access to intravitreal injections in some regions and may also negatively affect access to services for other vision-threatening eye conditions," the authors conclude.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Robert J. Campbell; Susan E. Bronskill; Chaim M. Bell; J. Michael Paterson; Marlo Whitehead; Sudeep S. Gill. Rapid Expansion of Intravitreal Drug Injection Procedures, 2000 to 2008: A Population-Based Analysis. Arch Ophthalmol, 2010; 128 (3): 359-362 [link]

Cite This Page:

JAMA and Archives Journals. "Treatment of retinal disease more frequently involves eye injections." ScienceDaily. ScienceDaily, 8 March 2010. <www.sciencedaily.com/releases/2010/03/100308171147.htm>.
JAMA and Archives Journals. (2010, March 8). Treatment of retinal disease more frequently involves eye injections. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2010/03/100308171147.htm
JAMA and Archives Journals. "Treatment of retinal disease more frequently involves eye injections." ScienceDaily. www.sciencedaily.com/releases/2010/03/100308171147.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins